leadf
logo-loader
viewMarrone Bio Innovations
(
NASDAQ:MBII
)

Marrone Bio Innovations sees its FY2020 revenue climb 31% on its improved product line and international presence

The company also said its net loss and adjusted EBITDA for the year improved by 46% and 31%, respectively

Marrone Bio Innovations -
Marrone Bio Innovations expects its momentum to continue, as it remains focused on expanding sales through its existing product portfolio as well as potential partnerships or acquisitions

Marrone Bio Innovations Inc (NASDAQ:MBII) reported a 31% year-over-year surge in its fiscal 2020 revenue to $38.4 million, driven largely by the company’s expanded  product line and international footprint.

Marrone also said its net loss and adjusted EBITDA for the year improved by 46% and 31%, respectively, achieving gross margins of 59.6% as a result of an improved product mix.

“We remain committed to our mission of rapidly advancing Marrone Bio toward profitability, and the results this year supported this objective,” Marrone Bio Innovations CEO Kevin Helash said in a statement.

READ: Marrone Bio CEO confident in FY2020 revenue numbers, lays out path to diversification in shareholder letter

“We expect this momentum to continue in 2021, with an ongoing focus on expanding sales both through our existing product portfolio and through potential strategic partnerships or acquisitions,” Helash added.

“Looking forward, we expect a strong first half of the year, with revenue growth in line with our annual revenue target.”

For its 4Q, Marrone saw revenue rise 15% to $7.7 million, marking the company’s tenth consecutive quarter of increased revenues, while its net loss for the period narrowed to $4.2 million from $10.1 million a year earlier as gross margins increased by 790 basis points to 63.7%.

The company added that its focus on cost management resulted in a reduction in operating expenses for both the fourth quarter and the full year.

Marrone Bio Innovations is leading the charge toward more environmentally-conscious effective pest management for farmers with its unique line of biological pesticides. Its products are made from naturally occurring substances such as microbes, bacteria, plant extracts, fatty acids or pheromones.

Contact Sean at sean@proactiveinvestors.com

Quick facts: Marrone Bio Innovations

Follow
NASDAQ:MBII

Price: 0.8199 USD

Market Cap: $144.54 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Proactive Presents a Livestream Event with Nextech AR Solutions

Proactive's Steve Darling presents a Livestream Chat with NextTech AR Solutions Joining the chat Evan Gappelberg - CEO and Founder Paul Duffy - President and Chairman of the Board Mirjana Prpa - AR Product Manager and Head of AI Division Baran Korkmaz - Founder of ARway

52 minutes ago

2 min read